Pneumologie

Adolescence to early adulthood transition in French severe asthmatic

Adolescence to early adulthood transition in French severe asthmatic children treated with omalizumab

BACKGROUND

Transition from adolescence to early adulthood is a critical time for severe asthmatic children. Data regarding asthma care are lacking.

OBJECTIVES

To describe omalizumab (OMA) exposure and medical visits over the adolescent (16-17years (y)) to young adult (18-19y) period in asthma patients..

find the whole article here ==>https://doi.org/10.1183/13993003.congress-2022.2897

Authors
C.Taillé, M. Humbert, A. Bourdin, R. Niarra, C. Thonnelier, A. Lajoinie, A. Rigault, M. Molimard, et A. Deschildre.

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Real-life omalizumab exposure and discontinuation
Pneumologie

Real-life omalizumab exposure and discontinuation

Persistence and Patterns of Exposure to Omalizumab
Pneumologie

Persistence and Patterns of Exposure to Omalizumab

Economic Burden of Severe Asthma With Omalizumab
Pneumologie

Economic Burden of Severe Asthma With Omalizumab